BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AstraZeneca (AZN) Norway Standardizes On Siebel Pharma (SEBL) To Maximize Sales And Marketing Effectiveness; Leading Pharmaceutical Company Further Aligns Marketing And Sales Business Processes To Strengthen Relationships With Health Care Customers


10/19/2005 5:13:04 PM

BARCELONA, Spain--(BUSINESS WIRE)--April 18, 2005--Siebel Systems, Inc. (Nasdaq:SEBL), the leading provider of customer-facing solutions, today announced that AstraZeneca Norway, a subsidiary of the leading pharmaceutical company, has selected Siebel Pharma to spearhead its program to maximize marketing and sales efficiency and effectiveness. The company will deploy Siebel's industry-specific CRM solution, including Siebel Pharma, Siebel Pharma Field Analytics and Siebel Pharma Marketing, to its sales and marketing professionals to capture and analyze all interactions with more than 15,000 physicians, hospital professionals and pharmacy customers across multiple channels. This integrated customer view will enable AstraZeneca Norway to develop profitable and lasting customer relationships. "AstraZeneca Norway's continued growth depends on being able to identify, win and retain multiple groups of pharmaceutical customers," said Stephan Pignatel, Head of Strategic Planning and Market Analysis, AstraZeneca Norway. "Siebel Pharma will enable AstraZeneca to enhance the company's sales effectiveness and help develop satisfying and long-term customer relationships. We are impressed by the rich pharmaceutical industry specific functionality, ease of use and robust analytic capabilities of Siebel's solution."

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES